Calian Secures $250M Contract Amendment to Support Canadian Armed Forces

Calian Group ( (TSE:CGY) ) just unveiled an update.

Calian Group Ltd. has announced a $250 million amendment to its Health Care Provider Recruitment contract with Canada’s Department of National Defence, reinforcing its commitment to the Canadian Armed Forces by ensuring the continued delivery of essential health services. This contract amendment consolidates unspent funds from a previous option period with planned funding for the next, contributing to Calian’s $1.6 billion contract backlog, and highlights the company’s ongoing partnership with government and military organizations, bolstering its position as a key player in Canada’s defence sector.

The most recent analyst rating on (TSE:CGY) stock is a Buy with a C$75.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Spark’s Take on TSE:CGY Stock

According to Spark, TipRanks’ AI Analyst, TSE:CGY is a Neutral.

Calian Group Ltd. exhibits strong growth potential driven by strategic acquisitions and solid performance in the defense sector. However, the high valuation and challenges in the ITCS segment pose risks. Despite these challenges, the company maintains a stable financial position with positive corporate developments supporting future growth.

To see Spark’s full report on TSE:CGY stock, click here.

More about Calian Group

Calian Group Ltd. is a mission-critical solutions company that operates in the defence, space, healthcare, and other strategic critical infrastructure sectors. Headquartered in Ottawa, Calian provides innovative healthcare, communications, learning, and cybersecurity solutions across North American, European, and international markets.

Average Trading Volume: 40,288

Technical Sentiment Signal: Buy

Current Market Cap: C$572.1M

Find detailed analytics on CGY stock on TipRanks’ Stock Analysis page.